Long-term outcomes of refractory neurosarcoidosis treated with infliximab
Crossref DOI link: https://doi.org/10.1007/s00415-017-8444-9
Published Online: 2017-03-04
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cohen Aubart, Fleur
Bouvry, Diane
Galanaud, Damien
Dehais, Caroline
Mathey, Guillaume
Psimaras, Dimitri
Haroche, Julien
Pottier, Corinne
Hie, Miguel
Mathian, Alexis
Devilliers, Hervé
Nunes, Hilario
Valeyre, Dominique
Amoura, Zahir
License valid from 2017-03-04